Syneron Candela is slated to acquire Ellipse, a medtech firm that develops Intense Pulse Light and laser-based platforms for a wide variety of medical and aesthetic skin treatments. Terms of the deal were not disclosed.
Ellipse's key products include Nordlys, a multi-application, multi-technology IPL and Nd:YAG platform for vascular and pigmented lesions, as well as hair removal. The Nordlys also offers a fractionated 1550 nm handpiece for skin resurfacing. Other products include an IPL-only system used for skin rejuvenation, facial veins and hair removal, as well as a fractional non-ablative laser system used for skin resurfacing.
"The acquisition of Ellipse allows Syneron Candela to strengthen its footprint in the multi-application space and provide our customers a comprehensive portfolio. Syneron Candela's best-in-class laser and energy-based technologies are now coupled with a trusted IPL technology that is well respected by physicians," Geoffrey Crouse, CEO of Syneron Candela said in a release.
Wayland, MA-based Syneron Candela’s plan to acquire Ellipse follows substantial M&A activity that occurred in the aesthetic device market in 2017.
The mergers began when Allergan announced it would acquire Zeltic Aesthetics, acompany known for its CoolSculpting System, which reduces fat with a body contouring process based on cryolipolysis, for $2.475 billion.
A day after Allergan made its announcement, Hologic made a $1.65 billion offer to acquire Cynosure, which also offers body contouring.